Transcriptome Analysis Reveals Significant Differences in Gene Expression of Malignant Pheochromocytoma or Paraganglioma

Abstract EN

Prediction of malignant behavior of pheochromocytoma (PC) or paraganglioma (PG) is of limited value.

The Cancer Genome Atlas (TCGA) and the French ‘Cortico et Médullosurrénale: les Tumeurs Endocrines’ (COMETE) network in Paris (France) facilitate accurate differentiation of malignant PC/PG based on genetic information.

Therefore, the objective of this transcriptome analysis is to identify the prognostic genes underlying the differentiation of malignant PC/PG in the TCGA and COMETE databases.

TCGA carries data pertaining to multigenomic analysis of 173 PC/PG surgical resection samples while the COMETE cohort contains data involving 188 PC/PG surgical resection samples.

Clinical information and mRNA expression datasets were downloaded from TCGA and COMETE databases.

Based on eligibility criteria, 58 of 173 PC/PG samples in TCGA and 171 of 188 PC/PG samples collected by the COMETE network were selected.

Using Ingenuity Pathway Analysis, the mRNA expression of malignant and benign PC/PG was compared.

The 58 samples in TCGA included 11 malignant and 47 benign cases.

Among the 171 samples obtained from the COMETE cohort, 19 were malignant and 152 were benign.

A comparative analysis of the mRNA expression data of the two databases revealed that 11 up/downregulated pathways involved in malignant PC/PG were related to cancer signaling, metabolic alteration, and prominent mitosis, whereas 6 upregulated genes and 1 downregulated gene were significantly enriched in the functional annotation pathways.

The TCGA and COMETE databases showed differences in mRNA expression associated with malignant and benign PC/PG.

Improved recognition of prognostic genes facilitates the diagnosis and treatment of PC/PG.